Home - Products - Others - Other Targets - Hydroumbellic acid

Hydroumbellic acid

CAS No. 5631-68-5

Hydroumbellic acid( —— )

Catalog No. M18814 CAS No. 5631-68-5

Hydroumbellic acid is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 3-(2, 4-dihydroxyphenyl)prop-2-enoic acid.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	37	In Stock
10MG	29	In Stock
25MG	48	In Stock
50MG	68	In Stock
100MG	101	In Stock
200MG	148	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Hydroumbellic acid
Note

Research use only, not for human use.
Brief Description

Hydroumbellic acid is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 3-(2, 4-dihydroxyphenyl)prop-2-enoic acid.
Description

Hydroumbellic acid is a predicted metabolite generated by BioTransformer1 that is produced by the metabolism of 3-(2, 4-dihydroxyphenyl)prop-2-enoic acid. It is generated by abkar1 enzyme via a reduction-of-alpha-beta-unsaturated-compounds-pattern1 reaction. This reduction-of-alpha-beta-unsaturated-compounds-pattern1 occurs in human gut microbiota.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Tyrosinase
Research Area

Others-Field
Indication

——

Chemical Information

CAS Number

5631-68-5
Formula Weight

182.17
Molecular Formula

C9H10O4
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 250 mg/mL (1372.34 mM)
SMILES

OC(=O)CCc1c(O)cc(O)cc1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Khatib S, et al. J Med Chem. 2007 May 31;50(11):2676-81.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

JMJD6 inhibitor WL12

2H-1-Benzopyran-2-one, 3-(3H-imidazo[4,5-c]pyridin-2-yl)-6-methyl- is a first-in-class JMJD6 inhibitor and was shown to be able to suppress JMJD6-dependent cancer cell proliferation including cervical and liver cancer cells.
MERS-CoV-IN-1

MERS-CoV-IN-1 exhibits excellent inhibitory activity against coronavirus.It is useful as a pharmaceutical composition for preventing coronavirus-induced diseases (MERS-CoV and SARS).
Sibrotuzumab

Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP) and is used in the study of colorectal cancer and non-small cell lung cancer.

Sign In Join Free